GANECT Trademark

Trademark Overview


On Wednesday, November 6, 2013, a trademark application was filed for GANECT with the United States Patent and Trademark Office. The USPTO has given the GANECT trademark a serial number of 79140559. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, February 19, 2021. This trademark is owned by Astellas Pharma Inc.. The GANECT trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
ganect

General Information


Serial Number79140559
Word MarkGANECT
Filing DateWednesday, November 6, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, February 19, 2021
Registration Number4549833
Registration DateTuesday, June 17, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, November 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, December 4, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 4, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, October 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 7, 2014NOTIFICATION PROCESSED BY IB
Friday, July 18, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 18, 2014FINAL DISPOSITION PROCESSED
Thursday, July 17, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 17, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Friday, March 28, 2014NOTIFICATION PROCESSED BY IB
Wednesday, March 12, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 12, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 12, 2014NOTICE OF PUBLICATION
Tuesday, February 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 24, 2014ASSIGNED TO EXAMINER
Saturday, January 4, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, December 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 27, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords


ganect human vaccines